UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Nature communications, 2020-06, Vol.11 (1), p.3187-3187, Article 3187

2020

Volltextzugriff (PDF)

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

Nature communications, 2020-02, Vol.11 (1), p.790-790, Article 790

2020

Volltextzugriff (PDF)

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry

Nature communications, 2023-03, Vol.14 (1), p.1601-1601, Article 1601

2023

Volltextzugriff (PDF)

Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice

Blood, 2013-08, Vol.122 (5), p.781-790

2013

Volltextzugriff (PDF)

Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection

Leukemia research reports, 2022, Vol.18, p.100353-100353, Article 100353

2022

Volltextzugriff (PDF)

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

Molecular therapy, 2016-01, Vol.24 (1), p.166-174

2016

Volltextzugriff (PDF)

Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.188, Article 188

2019

Volltextzugriff (PDF)

Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.577-587

2015

Volltextzugriff (PDF)

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

Molecular therapy. Oncolytics, 2018-12, Vol.11, p.1-13

2018

Volltextzugriff (PDF)

Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies

Clinical cancer research, 2018-09, Vol.24 (17), p.4215-4224

2018

Volltextzugriff (PDF)

Mechanism matters: A 10-year experience of ballistic injuries of the upper extremity

Injury, 2023-07, Vol.54 (7), p.110755-110755, Article 110755

2023

Volltextzugriff (PDF)

Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses

Molecular therapy, 2020-12, Vol.28 (12), p.2540-2552

2020

Volltextzugriff (PDF)

Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy

Molecular therapy, 2017-04, Vol.25 (4), p.962-975

2017

Volltextzugriff (PDF)

Antibiotic Prophylaxis and Infectious Complications in Isolated Gunshot Wounds to the Upper Extremity

Hand (New York, N.Y.), 2024-06, Vol.19 (4), p.587-593

2024

Volltextzugriff (PDF)

Immunogenicity of self tumor associated proteins is enhanced through protein truncation

Molecular therapy. Oncolytics, 2016, Vol.3 (C), p.16030-16030, Article 16030

2016

Volltextzugriff (PDF)

Brachial Gunshot Wounds: Injury Patterns and Considerations for Managing the Abnormal Neurological Examination

Hand (New York, N.Y.), 2024-01, p.15589447231221170-15589447231221170

2024

Volltextzugriff (PDF)

Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence

Cancer immunology research, 2017-11, Vol.5 (11), p.1029-1045

2017

Volltextzugriff (PDF)

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment

Cancer immunology research, 2019-05, Vol.7 (5), p.828-840

2019

Volltextzugriff (PDF)

Vesicular stomatitis virus expressing destabilized tumor associated antigens with enhanced MHC class I presentation to improve anti-tumor T cell responses

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.91-91.16

2020

Volltextzugriff (PDF)

VSV immunotherapy to improve treatment outcomes in a mouse model of metastatic melanoma

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.143-143.9

2016

Volltextzugriff (PDF)

Ad5 NULL -A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies

Clinical cancer research, 2018-09, Vol.24 (17), p.4215

2018

Volltextzugriff (PDF)

64. Generation of Tumor Cells Resistant to Oncolysis Is Mediated Through Virus Induced APOBEC Expression

Molecular therapy, 2016-05, Vol.24, p.S28-S28

2016

Volltextzugriff (PDF)

749. Escape from Tumor Dormancy Following Gene- or Viro-Therapies Is Mediated by Acquisition of a Phenotype in Which Innate Immune Surveillance Actively Drives Tumor Cell Recurrence

Molecular therapy, 2016-05, Vol.24, p.S296-S296

2016

Volltextzugriff (PDF)

63. Immunogenicity of Self Tumor Associated Antigens Is Enhanced Through Protein Truncation

Molecular therapy, 2016-05, Vol.24, p.S28-S28

2016

Volltextzugriff (PDF)

418. Effective Treatment of Oligometastatic Melanoma Using Combination VSV Viroimmunotherapy and Stereotactic Radiotherapy

Molecular therapy, 2015-05, Vol.23, p.S165-S166

2015

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry

Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice

Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity

Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies

Mechanism matters: A 10-year experience of ballistic injuries of the upper extremity

Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses

Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy

Antibiotic Prophylaxis and Infectious Complications in Isolated Gunshot Wounds to the Upper Extremity

Immunogenicity of self tumor associated proteins is enhanced through protein truncation

Brachial Gunshot Wounds: Injury Patterns and Considerations for Managing the Abnormal Neurological Examination

Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment

Vesicular stomatitis virus expressing destabilized tumor associated antigens with enhanced MHC class I presentation to improve anti-tumor T cell responses

VSV immunotherapy to improve treatment outcomes in a mouse model of metastatic melanoma

Ad5 NULL -A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies

64. Generation of Tumor Cells Resistant to Oncolysis Is Mediated Through Virus Induced APOBEC Expression

749. Escape from Tumor Dormancy Following Gene- or Viro-Therapies Is Mediated by Acquisition of a Phenotype in Which Innate Immune Surveillance Actively Drives Tumor Cell Recurrence

63. Immunogenicity of Self Tumor Associated Antigens Is Enhanced Through Protein Truncation

418. Effective Treatment of Oligometastatic Melanoma Using Combination VSV Viroimmunotherapy and Stereotactic Radiotherapy

Suchergebnisse filtern